首页 > 最新文献

Expert Review of Obstetrics & Gynecology最新文献

英文 中文
Role of ultrasound on the labor ward 超声在产房中的作用
Pub Date : 2012-11-01 DOI: 10.1586/EOG.12.58
M. Ramphul, D. Murphy
Ultrasound is an important investigational tool used in the antenatal period, and is increasingly being used in labor and the peripartum period. Research over the past two decades has focused on establishing objective ultrasound parameters to define fetal gestational age/estimated fetal weight in labor, to identify fetuses at risk of compromise in labor, to predict mode of delivery and to enhance the safety of operative deliveries. This review outlines the role of these various uses of ultrasound and explores whether there may be a role for routine use of ultrasound in the management of labor and delivery.
超声是一种重要的产前检查工具,越来越多地用于分娩和围产期。过去二十年的研究重点是建立客观的超声参数,以确定胎儿胎龄/估计分娩时胎儿体重,识别有分娩危险的胎儿,预测分娩方式,提高手术分娩的安全性。这篇综述概述了超声的这些不同用途的作用,并探讨了是否有可能在劳动和分娩管理中常规使用超声的作用。
{"title":"Role of ultrasound on the labor ward","authors":"M. Ramphul, D. Murphy","doi":"10.1586/EOG.12.58","DOIUrl":"https://doi.org/10.1586/EOG.12.58","url":null,"abstract":"Ultrasound is an important investigational tool used in the antenatal period, and is increasingly being used in labor and the peripartum period. Research over the past two decades has focused on establishing objective ultrasound parameters to define fetal gestational age/estimated fetal weight in labor, to identify fetuses at risk of compromise in labor, to predict mode of delivery and to enhance the safety of operative deliveries. This review outlines the role of these various uses of ultrasound and explores whether there may be a role for routine use of ultrasound in the management of labor and delivery.","PeriodicalId":12242,"journal":{"name":"Expert Review of Obstetrics & Gynecology","volume":"17 1","pages":"615-625"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78034693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Complications and challenges in management of the obese expectant mother 肥胖孕妇处理的并发症和挑战
Pub Date : 2012-11-01 DOI: 10.1586/EOG.12.53
Dzhamala Gilmandyar, Paula Zozzaro-Smith, L. Thornburg
Obesity is increasing worldwide, especially in the USA. This is reflected in the pregnant population, with up to a third of women classified as obese during their pregnancy. It poses a challenge to the practitioners throughout pregnancy, labor and delivery, as well as in postpartum care. Obesity is also a risk factor for multiple pregnancy complications including gestational diabetes, hypertensive disorders of pregnancy, iatrogenic preterm birth, fetal macrosomia and intrauterine fetal demise. Antenatal care challenges, including limitation of fetal ultrasound evaluation, contribute to a greater number of undetected anomalies and poor fetal weight estimation. Maternal risks such as increased rates of cesarean section, and subsequent postoperative complications such as wound infection and venous thromboembolic events, are increasing in prevalence. Optimal prenatal care requires knowledge of and attention to each of these risks and appropriate patient counseling.
肥胖症在世界范围内呈上升趋势,尤其是在美国。这反映在怀孕人群中,多达三分之一的女性在怀孕期间被归类为肥胖。它提出了一个挑战,从业人员在整个怀孕,劳动和分娩,以及在产后护理。肥胖也是多种妊娠并发症的危险因素,包括妊娠糖尿病、妊娠高血压疾病、医源性早产、巨大胎儿和宫内死胎。产前保健方面的挑战,包括胎儿超声评估的限制,导致大量未被发现的异常和胎儿体重估计不佳。产妇风险,如剖宫产率增加,以及随后的术后并发症,如伤口感染和静脉血栓栓塞事件,正在增加。最佳的产前护理需要了解和注意这些风险和适当的患者咨询。
{"title":"Complications and challenges in management of the obese expectant mother","authors":"Dzhamala Gilmandyar, Paula Zozzaro-Smith, L. Thornburg","doi":"10.1586/EOG.12.53","DOIUrl":"https://doi.org/10.1586/EOG.12.53","url":null,"abstract":"Obesity is increasing worldwide, especially in the USA. This is reflected in the pregnant population, with up to a third of women classified as obese during their pregnancy. It poses a challenge to the practitioners throughout pregnancy, labor and delivery, as well as in postpartum care. Obesity is also a risk factor for multiple pregnancy complications including gestational diabetes, hypertensive disorders of pregnancy, iatrogenic preterm birth, fetal macrosomia and intrauterine fetal demise. Antenatal care challenges, including limitation of fetal ultrasound evaluation, contribute to a greater number of undetected anomalies and poor fetal weight estimation. Maternal risks such as increased rates of cesarean section, and subsequent postoperative complications such as wound infection and venous thromboembolic events, are increasing in prevalence. Optimal prenatal care requires knowledge of and attention to each of these risks and appropriate patient counseling.","PeriodicalId":12242,"journal":{"name":"Expert Review of Obstetrics & Gynecology","volume":"35 1","pages":"585-593"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78369831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Associated risks of inducing labor at term in an uncomplicated pregnancy 无并发症妊娠足月引产的相关风险
Pub Date : 2012-09-01 DOI: 10.1586/EOG.12.42
R. Grivell, J. Dodd
{"title":"Associated risks of inducing labor at term in an uncomplicated pregnancy","authors":"R. Grivell, J. Dodd","doi":"10.1586/EOG.12.42","DOIUrl":"https://doi.org/10.1586/EOG.12.42","url":null,"abstract":"","PeriodicalId":12242,"journal":{"name":"Expert Review of Obstetrics & Gynecology","volume":"29 1","pages":"403-405"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84155314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Ultrasound assessment in adnexal masses: an update 附件肿块的超声评估:最新进展
Pub Date : 2012-09-01 DOI: 10.1586/EOG.12.49
J. Alcázar, M. Aubá, Á. Ruiz-Zambrana, B. Olartecoechea, D. Diaz, J. Hidalgo, L. Pineda, J. Utrilla-Layna
Adnexal masses are among the most frequent pathologic conditions in gynecologic practice. Ultrasound is widely used for discriminating benign from malignant adnexal masses. Despite the significant amount of papers published about this topic in the last 30 years, research still goes on and new data appear almost every year. The objective of the present paper is to review and update published literature in the last 5 years about adnexal masses. From the studies reported in recent years it can be concluded that the use of pattern recognition by an expert examiner renders the best result in terms of diagnostic performance. Scoring systems or logistic models are not superior to subjective impression of an expert examiner. New technologies such as contrast ultrasound imaging, ovarian HistoScanning and 3D ultrasound are emerging.
附件肿块是妇科实践中最常见的病理状况之一。超声被广泛用于鉴别附件肿块的良恶性。尽管在过去的30年里,关于这个话题的论文发表了大量,但研究仍在继续,几乎每年都有新的数据出现。本文的目的是回顾和更新近5年来发表的关于附件肿块的文献。从近年来的研究报告可以得出结论,由专家审查员使用模式识别在诊断性能方面取得了最好的结果。评分系统或逻辑模型并不优于专家考官的主观印象。超声造影、卵巢组织扫描和3D超声等新技术正在兴起。
{"title":"Ultrasound assessment in adnexal masses: an update","authors":"J. Alcázar, M. Aubá, Á. Ruiz-Zambrana, B. Olartecoechea, D. Diaz, J. Hidalgo, L. Pineda, J. Utrilla-Layna","doi":"10.1586/EOG.12.49","DOIUrl":"https://doi.org/10.1586/EOG.12.49","url":null,"abstract":"Adnexal masses are among the most frequent pathologic conditions in gynecologic practice. Ultrasound is widely used for discriminating benign from malignant adnexal masses. Despite the significant amount of papers published about this topic in the last 30 years, research still goes on and new data appear almost every year. The objective of the present paper is to review and update published literature in the last 5 years about adnexal masses. From the studies reported in recent years it can be concluded that the use of pattern recognition by an expert examiner renders the best result in terms of diagnostic performance. Scoring systems or logistic models are not superior to subjective impression of an expert examiner. New technologies such as contrast ultrasound imaging, ovarian HistoScanning and 3D ultrasound are emerging.","PeriodicalId":12242,"journal":{"name":"Expert Review of Obstetrics & Gynecology","volume":"3 1","pages":"441-449"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84193653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Treatment of twin–twin transfusion syndrome 双胎输血综合征的治疗
Pub Date : 2012-09-01 DOI: 10.1586/EOG.12.45
A. Rossi
Twin–twin transfusion syndrome is characterized by unequal blood exchange from the donor twin to the recipient co-twin through placental vascular anastomoses. Treatment of twin–twin transfusion syndrome consists of serial amnioreduction, septostomy, laser photocoagulation of placental vessels and umbilical cord occlusion of the apparently sick twin. Amnioreduction reduces maternal discomfort due to polyhydramnios and improves fetal circulation by reducing amniotic fluid pressure on the placenta. Septostomy equalizes amniotic fluid pressure between the two gestational sacs. Laser therapy interrupts intertwin blood shunting and restores two independent circulations. Umbilical cord occlusion is offered when signs of imminent death are present, such as hydrops and cardiac failure. Laser therapy is associated with increased neonatal survival rates and lower risk of adverse outcomes compared with other treatments.
双卵输血综合征的特点是供体双胞胎通过胎盘血管吻合口向受体双胞胎交换不均匀的血液。治疗双胎输血综合征包括一系列羊膜切除、中隔造口术、胎盘血管激光光凝术和明显患病的双胞胎脐带闭塞术。羊膜还原术减少了由于羊水过多引起的产妇不适,并通过减少胎盘上的羊水压力来改善胎儿循环。中隔造口术使两个妊娠囊之间的羊水压力相等。激光治疗阻断双胞间的血液分流,恢复两个独立的循环。当出现即将死亡的迹象,如水肿和心力衰竭时,提供脐带阻断。与其他治疗方法相比,激光治疗可提高新生儿存活率,降低不良后果风险。
{"title":"Treatment of twin–twin transfusion syndrome","authors":"A. Rossi","doi":"10.1586/EOG.12.45","DOIUrl":"https://doi.org/10.1586/EOG.12.45","url":null,"abstract":"Twin–twin transfusion syndrome is characterized by unequal blood exchange from the donor twin to the recipient co-twin through placental vascular anastomoses. Treatment of twin–twin transfusion syndrome consists of serial amnioreduction, septostomy, laser photocoagulation of placental vessels and umbilical cord occlusion of the apparently sick twin. Amnioreduction reduces maternal discomfort due to polyhydramnios and improves fetal circulation by reducing amniotic fluid pressure on the placenta. Septostomy equalizes amniotic fluid pressure between the two gestational sacs. Laser therapy interrupts intertwin blood shunting and restores two independent circulations. Umbilical cord occlusion is offered when signs of imminent death are present, such as hydrops and cardiac failure. Laser therapy is associated with increased neonatal survival rates and lower risk of adverse outcomes compared with other treatments.","PeriodicalId":12242,"journal":{"name":"Expert Review of Obstetrics & Gynecology","volume":"234 1","pages":"477-482"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77339556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obesity and pregnancy: implications for maternal and fetal outcomes 肥胖与妊娠:对母体和胎儿结局的影响
Pub Date : 2012-09-01 DOI: 10.1586/EOG.12.47
M. Lučovnik, N. Tul, I. Blickstein
{"title":"Obesity and pregnancy: implications for maternal and fetal outcomes","authors":"M. Lučovnik, N. Tul, I. Blickstein","doi":"10.1586/EOG.12.47","DOIUrl":"https://doi.org/10.1586/EOG.12.47","url":null,"abstract":"","PeriodicalId":12242,"journal":{"name":"Expert Review of Obstetrics & Gynecology","volume":"8 1","pages":"399-401"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84813455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
World Congress on Building Consensus in Gynecology, Infertility and Perinatology: controversies in obstetrics, gynecology and infertility 建立妇科、不孕症和围产期共识世界大会:产科、妇科和不孕症的争议
Pub Date : 2012-09-01 DOI: 10.1586/eog.12.43
P. Barri
World Congress on Building Consensus in Gynecology, Infertility and PerinatologyBarcelona, Spain, 3–6 May 2012.On 3–6 May 2012 The World Congress on Building Consensus out of Controversies in Gynecology, Infertility and Perinatology was held in Barcelona (Spain) and as usual there was discussion of topics from the disciplines of obstetrics, gynecology and infertility. The congress was very well organized, with a very satisfactory attendance of approximately 1000 participants.
2012年5月3-6日,西班牙巴塞罗那,世界妇科、不孕症和围产期医学共识大会。2012年5月3日至6日,在巴塞罗那(西班牙)举行了关于在妇科、不孕症和围产期医学争议中建立共识的世界大会,与往常一样,会上讨论了来自产科、妇科和不孕症学科的主题。大会组织得很好,约有1000人出席,令人满意。
{"title":"World Congress on Building Consensus in Gynecology, Infertility and Perinatology: controversies in obstetrics, gynecology and infertility","authors":"P. Barri","doi":"10.1586/eog.12.43","DOIUrl":"https://doi.org/10.1586/eog.12.43","url":null,"abstract":"World Congress on Building Consensus in Gynecology, Infertility and PerinatologyBarcelona, Spain, 3–6 May 2012.On 3–6 May 2012 The World Congress on Building Consensus out of Controversies in Gynecology, Infertility and Perinatology was held in Barcelona (Spain) and as usual there was discussion of topics from the disciplines of obstetrics, gynecology and infertility. The congress was very well organized, with a very satisfactory attendance of approximately 1000 participants.","PeriodicalId":12242,"journal":{"name":"Expert Review of Obstetrics & Gynecology","volume":"1 1","pages":"411-412"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79899982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Histone deacetylase inhibitors as therapeutics for endometriosis 组蛋白去乙酰化酶抑制剂治疗子宫内膜异位症
Pub Date : 2012-09-01 DOI: 10.1586/EOG.12.52
Xin Li, Xi-shi Liu, Sun-Wei Guo
Endometriosis is a common gynecological disorder affecting mostly women of reproductive age. Its presenting symptoms include dysmenorrhea, chronic pelvic pain and infertility. There is a pressing need to develop more efficacious therapeutics, preferably with improved safety and cost profiles. Unfortunately, thus far the drug development progress has been frustratingly slow. In this article, published data in support of the notion that endometriosis is an epigenetic disease are reviewed. The desirable properties of histone deacetylase inhibitors as therapeutics for treating endometriosis are enumerated, and the obstacles in evaluating histone deacetylases in clinical trials are listed. It is argued that, from the drug discovery standpoint, repurposing of valproic acid is justifiable. Finally, the areas in need of further research are exposed.
子宫内膜异位症是一种常见的妇科疾病,主要影响育龄妇女。其主要症状包括痛经、慢性盆腔疼痛和不孕症。迫切需要开发更有效的治疗方法,最好是提高安全性和成本。不幸的是,到目前为止,药物开发进展缓慢得令人沮丧。本文回顾了支持子宫内膜异位症是一种表观遗传疾病这一观点的已发表数据。列举了组蛋白去乙酰化酶抑制剂作为治疗子宫内膜异位症的理想特性,并列出了在临床试验中评估组蛋白去乙酰化酶的障碍。有人认为,从药物发现的角度来看,丙戊酸的再利用是合理的。最后,指出了需要进一步研究的领域。
{"title":"Histone deacetylase inhibitors as therapeutics for endometriosis","authors":"Xin Li, Xi-shi Liu, Sun-Wei Guo","doi":"10.1586/EOG.12.52","DOIUrl":"https://doi.org/10.1586/EOG.12.52","url":null,"abstract":"Endometriosis is a common gynecological disorder affecting mostly women of reproductive age. Its presenting symptoms include dysmenorrhea, chronic pelvic pain and infertility. There is a pressing need to develop more efficacious therapeutics, preferably with improved safety and cost profiles. Unfortunately, thus far the drug development progress has been frustratingly slow. In this article, published data in support of the notion that endometriosis is an epigenetic disease are reviewed. The desirable properties of histone deacetylase inhibitors as therapeutics for treating endometriosis are enumerated, and the obstacles in evaluating histone deacetylases in clinical trials are listed. It is argued that, from the drug discovery standpoint, repurposing of valproic acid is justifiable. Finally, the areas in need of further research are exposed.","PeriodicalId":12242,"journal":{"name":"Expert Review of Obstetrics & Gynecology","volume":"30 1","pages":"451-466"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81022623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Injectable bulking agents in fecal and urinary incontinence: current agents, techniques and rationale for their use 注射填充剂治疗大便失禁和尿失禁:目前的药物、技术和使用理由
Pub Date : 2012-09-01 DOI: 10.1586/EOG.12.50
C. Jaeger, A. Carrasco, D. Lightner
While the use of injectable bulking agents in the treatment of stress urinary incontinence may be infrequently considered due to lack of permanence, properly injected agents can be a good initial, minimally invasive, therapy or an excellent second-line therapy in very complex patients. Proper patient counseling and selection are essential to successful treatment. The use of bulking agents in fecal incontinence is young, with the refined technique and defined outcomes yet to be determined.
虽然由于缺乏持久性,在治疗压力性尿失禁时可能很少考虑使用注射膨胀剂,但适当注射药物可以是一个良好的初始,微创治疗或非常复杂的患者的优秀二线治疗。适当的患者咨询和选择是成功治疗的关键。在大便失禁中使用膨化剂是很年轻的,技术的改进和明确的结果还有待确定。
{"title":"Injectable bulking agents in fecal and urinary incontinence: current agents, techniques and rationale for their use","authors":"C. Jaeger, A. Carrasco, D. Lightner","doi":"10.1586/EOG.12.50","DOIUrl":"https://doi.org/10.1586/EOG.12.50","url":null,"abstract":"While the use of injectable bulking agents in the treatment of stress urinary incontinence may be infrequently considered due to lack of permanence, properly injected agents can be a good initial, minimally invasive, therapy or an excellent second-line therapy in very complex patients. Proper patient counseling and selection are essential to successful treatment. The use of bulking agents in fecal incontinence is young, with the refined technique and defined outcomes yet to be determined.","PeriodicalId":12242,"journal":{"name":"Expert Review of Obstetrics & Gynecology","volume":"32 1","pages":"431-440"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74411477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hormonal strategy for the primary or secondary treatment of endometriosis 子宫内膜异位症的激素治疗策略
Pub Date : 2012-09-01 DOI: 10.1586/EOG.12.46
L. Lazzeri, C. Tosti, S. Pinzauti, C. Orlandini, S. Luisi, F. Petraglia
Endometriosis is a chronic inflammatory disease characterized by dysmenorrhea, dyspareunia and infertility, which may be treated surgically and/or medically. The medical treatment of endometriosis may be used as a first-line option, as an alternative to surgery and for postoperative adjuvant use. The most commonly used drugs are hormones, which act via two major strategies: iatrogenic menopause and pseudopregnancy. In both cases, the goal is to create a steady hormonal environment with inhibition of ovulation, suppressing the ectopic implants and reducing the inflammatory status as well as the associated pain symptoms. The blockade of the growth and activity of endometriotic lesions is obtained, and long-term or repeated courses of medication may be required to control symptoms. To obtain reduced ovarian activity, gonadotropin-releasing hormone analogs, gonadotropin-releasing hormone analog antagonists or aromatase inhibitors are currently used or are under investigation. Pseudopregnancy is obtained by th...
子宫内膜异位症是一种以痛经、性交困难和不孕症为特征的慢性炎症性疾病,可以通过手术和/或药物治疗。子宫内膜异位症的药物治疗可作为一线选择,作为手术的替代方案和术后辅助使用。最常用的药物是激素,它通过两种主要策略起作用:医源性更年期和假妊娠。在这两种情况下,目标是创造一个稳定的激素环境,抑制排卵,抑制异位植入物,减少炎症状态以及相关的疼痛症状。可以阻断子宫内膜异位症病变的生长和活动,可能需要长期或反复的药物治疗来控制症状。为了降低卵巢活性,目前正在使用或正在研究促性腺激素释放激素类似物、促性腺激素释放激素类似物拮抗剂或芳香酶抑制剂。假妊娠是由…
{"title":"Hormonal strategy for the primary or secondary treatment of endometriosis","authors":"L. Lazzeri, C. Tosti, S. Pinzauti, C. Orlandini, S. Luisi, F. Petraglia","doi":"10.1586/EOG.12.46","DOIUrl":"https://doi.org/10.1586/EOG.12.46","url":null,"abstract":"Endometriosis is a chronic inflammatory disease characterized by dysmenorrhea, dyspareunia and infertility, which may be treated surgically and/or medically. The medical treatment of endometriosis may be used as a first-line option, as an alternative to surgery and for postoperative adjuvant use. The most commonly used drugs are hormones, which act via two major strategies: iatrogenic menopause and pseudopregnancy. In both cases, the goal is to create a steady hormonal environment with inhibition of ovulation, suppressing the ectopic implants and reducing the inflammatory status as well as the associated pain symptoms. The blockade of the growth and activity of endometriotic lesions is obtained, and long-term or repeated courses of medication may be required to control symptoms. To obtain reduced ovarian activity, gonadotropin-releasing hormone analogs, gonadotropin-releasing hormone analog antagonists or aromatase inhibitors are currently used or are under investigation. Pseudopregnancy is obtained by th...","PeriodicalId":12242,"journal":{"name":"Expert Review of Obstetrics & Gynecology","volume":"15 1","pages":"467-476"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75991005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Expert Review of Obstetrics & Gynecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1